About Golden Helix

New Year, New You! How Diagnostic Labs Can Ride the Genomic Health Wave in 2026

Jan 6, 2026

As interest in personalized health grows, people are looking beyond traditional wellness trends to genomics for clinically actionable insights. Two areas stand out for diagnostic laboratories: pharmacogenomics (PGx) to optimize medication decisions, and rare disease genomics to shorten diagnostic odysseys. The public is increasingly receptive, and the market is expanding…

Read more →

Execution at Scale: Advancing Clinical Genomics with Confidence

Jan 1, 2026

We just concluded a defining year for Golden Helix. 2025 was about execution at scale. With major platform releases, national-level adoption, and meaningful progress across pharmacogenomics, oncology, and long-read sequencing, we strengthened our position as a trusted clinical genomics platform for laboratories operating in regulated, high-throughput environments. Below, we reflect…

Read more →

December 2025 | Customer Publications: Clinical Genomics Insights Across Infectious Disease, Pharmacogenomics, and Rare Kidney Disorders

Dec 30, 2025

December 2025 brings a diverse set of customer publications highlighting how advanced genomic analysis is being applied to real clinical and population-scale challenges, from infectious disease susceptibility to pharmacogenomics and rare kidney disorders. Together, these studies underscore the growing importance of integrated variant interpretation, scalable sequencing strategies, and rigorous clinical…

Read more →

Automating Couple’s Carrier Screening Workflows with VarSeq

Dec 16, 2025

Carrier screening, also referred to as preconception genetic screening, helps individuals and reproductive partners understand their risk of passing along autosomal recessive and X-linked genetic conditions to their children. This method is being increasingly adopted as a preventive, population-level health intervention that specifically benefits couple’s or individuals in the family…

Read more →

VSWarehouse for Genome Centers: Scalable, Secure Whole-Genome Infrastructure for Modern Sequencing Programs 

Dec 12, 2025

Thank you to everyone who joined our recent webcast, “VSWarehouse for Genome Centers: Scalable, Secure Whole-Genome Infrastructure for Modern Sequencing Programs,” presented by Gabe Rudy on December 10, 2025. We appreciate the strong attendance and the excellent questions regarding the operational and security needs of modern genome centers.  For those…

Read more →

Considering Data Quality: From Sequencing to Reporting

Dec 11, 2025

When quality metrics generated during secondary analysis are not incorporated into interpretation and reporting, variants are reported without the important context that could affect confidence in the call. The Golden Helix software suite has been designed to help you bring in quality metrics from secondary analysis through to interpretation and…

Read more →

Detect Cryptic Splicing Events with the New CI-SpliceAI Annotations in VarSeq

Dec 10, 2025

Aberrant splicing is a major cause of human disease, with an estimated 15–30% of pathogenic variants either disrupting an existing splice site or introducing a novel one [1]. While variants that alter the canonical AG/GT dinucleotides are straightforward to detect, those that affect the broader splice motif or activate cryptic…

Read more →

Challenging Genomic Regions: Paraphase Integration in VSWarehouse 3

Dec 9, 2025

Short-read sequencing often fails to capture clinically actionable information from challenging genomic regions. While long-read sequencing now enables accurate and comprehensive detection of complex variants, there are still regions of the genome that remain notoriously difficult to analyze. Unfortunately, many of these regions contain genes that are highly relevant to…

Read more →

Level Up Your Lab: Dx Mode Arrives in VarSeq 3.0.0

Dec 4, 2025

With our release of VarSeq 3.0.0, we’re excited to highlight one of the most impactful capabilities of our platform: Dx Mode. This program enables VarSeq to be used as a Class A Medical Device, supporting laboratories operating within the European In Vitro Diagnostic Regulation (IVDR). The use of Dx Mode…

Read more →

How VarSeq Supports Inherited Trait Discovery & Carrier Screening

Nov 28, 2025

As we gather around the table this season, many of us reflect on family and where we come from, what connects us, and what we pass on. In the field of genetics, these same concepts are explored through the study of inheritance and carrier screening. NGS analysis tools, such as…

Read more →

November 2025 | Customer Publications: Genetic Insights Into Rare Ocular and Fetal Phenotypes

Nov 25, 2025

Each month, we highlight new research from the scientific community that advances our understanding of complex genetic diseases and showcases the tools researchers rely on for precise variant interpretation. November’s publications explore three distinct phenotypes: congenital cataract, glaucoma, and fetal lymphatic or venous abnormalities, revealing how specific genetic mechanisms shape…

Read more →

Integrating PacBio Somatic Workflows into VSWarehouse 3.0

Nov 21, 2025

As long-read sequencing solidifies its role in clinical and translational research, labs are increasingly seeking streamlined methods to transition from raw data to actionable results. With the release of VSWarehouse 3.0, Golden Helix now supports a fully integrated implementation of PacBio’s somatic workflow, providing users with a powerful, centralized environment…

Read more →

Integrating Genomenon Cancer Knowledgebase (CKB) into VarSeq and VSClinical

Nov 19, 2025

Golden Helix’s VSClinical AMP guidelines platform, powered by our Golden Helix CancerKB has long been trusted by clinicians and researchers for generating report-ready clinical cancer biomarker interpretations. To further elevate the coverage and currency of our somatic variant evaluation capabilities, we’ve integrated Genomenon’s Cancer Knowledgebase (CKB) into both VarSeq and…

Read more →

Streamlining Carrier Analysis with VSClinical

Nov 13, 2025

Carrier screening is an important component of reproductive genetic testing, helping identify individuals or couples at increased risk of passing on inherited conditions to their children. When both partners carry a pathogenic or likely pathogenic variant in the same gene associated with an autosomal recessive condition, or when a pathogenic…

Read more →

Stop Hunting for Clinical Evidence: Let Golden Helix CancerKB Do the Work

Nov 11, 2025

Precision oncology moves fast, and labs need tools that can keep up. Golden Helix CancerKB is built for clinical labs that want high-quality, report-ready cancer interpretations without the manual workload or inconsistencies that slow teams down. Stay in the Loop with Golden Helix CancerKB Oncology doesn’t stand still and neither…

Read more →

Introducing VarSeq 3.0.0: Faster, Smarter, Fully Integrated with VSWarehouse 3

Nov 7, 2025

VarSeq 3.0.0 is officially here, and it’s one of our most significant releases yet! The headline feature of this update is full integration with VSWarehouse 3, including a new login system that supports both single-user mode and server-managed authentication. Users can now choose to work locally or seamlessly store projects…

Read more →

November Webcast: Simplifying Complex Cancer Data into Actionable Knowledge

Nov 6, 2025

As precision oncology evolves, clinicians and laboratories need tools that can both handle massive genomic datasets and translate those findings into clear, clinically actionable guidance. In our recent webcast, “Simplifying Complex Cancer Data into Actionable Knowledge with Golden Helix CancerKB,” we walked through how Golden Helix CancerKB can take clinical…

Read more →

Golden Helix to Attend AMP 2025 in Boston

Oct 30, 2025

Golden Helix is excited to exhibit at the Association for Molecular Pathology (AMP) 2025 Annual Meeting in Boston, Massachusetts, where we’ll showcase our newest advancements in variant interpretation, enterprise genomics, and scalable software deployment. Visit us at Booth #543 to explore how VSWarehouse and our Bring Your Own Cloud (BYOC)…

Read more →

October 2025 | Customer Publications: Driving Genomic Innovation with VarSeq

Oct 28, 2025

At Golden Helix, we’re proud to see how researchers worldwide continue using our software to accelerate discovery and improve clinical decision-making. These October 2025 publications highlight how VarSeq is advancing genetic research across cancer, hereditary disease, and molecular diagnostics. From identifying new variant mechanisms to expanding our understanding of genotype–phenotype…

Read more →

Clinical Variant Interpretation at Scale: Reflections from ASHG 2025

Oct 27, 2025

Recently, Golden Helix attended the ASHG 2025 conference, where we had the opportunity to showcase our partnership with Genomenon. This collaboration took center stage at both our booth and Genomenon’s CoLab session, Automating Genomic Workflows: Cutting Interpretation Time, Accelerating Turnaround, and Increasing Diagnostic Yield. Our discussions centered on a problem…

Read more →